Factors associated with treatment-emergent headache occurrence following RTMS to non-motor areas and the impact on treatment outcomes: a retrospective study
Juliana Corlier
BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is an FDA-approved, non-invasive treatment for Major Depressive Disorder (MDD). rTMS has a favorable safety profile, however, headaches are a common side effect. It is unclear which patients may be at greatest risk for headache, which device parameters might be associated with headache, and whether occurrence of headaches during rTMS affects eventual treatment outcome.MethodsThis retrospective study analyzed clinical records from 938